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The K1 gene of Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a 46-kDa transmembrane glycoprotein that possesses transforming
properties, initiates signaling pathways in B cells, and prevents apoptosis. Here, we demonstrate a mechanism for activation of the K1 promoter by
the Rta transactivator. Electrophoretic mobility shift assay (EMSA) analysis of the K1 promoter demonstrated that purified Rta protein bound to
the K1 promoter at three locations, independent of other DNA-binding factors. Transcriptional assays revealed that only two of these Rta DNA-
binding sites are functionally significant, and that they could impart Rta responsiveness to a heterologous E4 TATA box promoter. In addition,
TATA-binding protein (TBP) bound to a TATA box element located 25 bp upstream of the K1 transcription start site and was also shown to
associate with Rta by coimmunoprecipitation analysis. Rta transactivation may therefore be mediated in part through recruitment of TBP to target
promoters.
© 2006 Elsevier Inc. All rights reserved.Keywords: KSHV; HHV8; K1; Rta; Orf50; TranscriptionIntroduction
Kaposi's sarcoma-associated herpesvirus (KSHV), also
known as human herpesvirus 8 (HHV8), has been linked to
the development of Kaposi's sarcoma (KS) and is also
associated with two B cell lymphomas—primary effusion
lymphoma (PEL) and multicentric Castleman's disease (MCD)
(Cesarman et al., 1995; Ganem, 1998; Moore and Chang, 1995;
Soulier et al., 1995). KSHV is closely related to rhesus monkey
rhadinovirus (RRV), murine herpesvirus 68, and herpesvirus
saimiri (HVS) and based on sequence homology has been
classified as a gamma 2 herpesvirus or rhadinovirus (Albrecht et
al., 1992; Alexander et al., 2000; Virgin et al., 1997).⁎ Corresponding author. Mailing Address: Lineberger Comprehensive Cancer
Center, CB #7295 University of North Carolina, Chapel Hill, NC 27599, USA.
Fax: +1 919 966 9673.
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1 Present address: Division of Biotechnology, College of Life Sciences and
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doi:10.1016/j.virol.2006.02.007The first open reading frame of KSHV, OrfK1, encodes a
46-kDa transmembrane glycoprotein(Lee et al., 1998b). K1 is
located at the far left end of the KSHV genome, a position
occupied by the saimiri transformation-associated protein
(STP) in the HVS genome and R1 in the RRV genome
(Damania et al., 1999; Murthy et al., 1989). Although K1 and
R1 occupy positions equivalent to HVS STP, they possess no
obvious sequence similarity with STP (Damania et al., 1999;
Lee et al., 1998b; Murthy et al., 1989). HVS STP is necessary
for the immortalization of primary T lymphocytes and the
development of lymphomas in marmosets(Duboise et al.,
1998). Like its positional homolog, K1 has also been shown to
immortalize marmoset lymphocytes to IL-2-independent
proliferation when substituted for STP in the context of
HVS. K1 induces foci formation and morphological changes
in Rat-1 fibroblasts (Lee et al., 1998b). Finally, transgenic
animals expressing K1 develop spindle-cell sarcomatoid
tumors and malignant plasmablastic lymphomas (Prakash et
al., 2002). K1 is expressed in KS lesions, primary effusion
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tissues (Bowser et al., 2002; Lagunoff and Ganem, 1997; Lee
et al., 2003; Samaniego et al., 2001). We have previously
demonstrated that the K1 promoter is activated by expression
of Rta in B cells, endothelial and epithelial cells (Bowser et al.,
2002). The K1 protein contains an immunoreceptor tyrosine-
based activation motif (ITAM) in its cytoplasmic tail(Lee et
al., 1998a). Expression of K1 protein in B cells leads to the
phosphorylation of signaling proteins, mobilization of intra-
cellular calcium, and ultimately the activation of transcription
factors such as NFAT and AP-1(Lee et al., 2002; Samaniego et
al., 2001). Signaling through the ITAM has also been shown to
activate the Akt signaling pathway and to inhibit apoptosis
induced by FKHR proteins and Fas signaling (Tomlinson and
Damania, 2004). Samaniego et al. demonstrated that K1
expression leads to the activation of NF-κB-dependent
promoters(Samaniego et al., 2001).
Similar to other gammaherpesviruses, KSHV establishes a
latent infection in the majority of infected cells. During latency,
only a small subset of genes is expressed to prevent cell death
and maintain the viral genome in a circular, episomal state.
However, in a small subset of cells within KS lesions and in
cultured PEL cells, the virus is reactivated and expresses lytic
genes that ultimately lead to the production of progeny virions
(Renne et al., 1996; Staskus et al., 1997, 1999; Zhong et al.,
1996). This limited lytic reactivation is apparently vital to the
maintenance of KS lesions since treatment with ganciclovir was
shown to reduce the risk of KS development(Martin et al.,
1999).
The switch from latent to lytic KSHV infection is initiated by
the product of open reading frame 50 (Orf50), also known as
replication and transcription activator (Rta), ART, or Lyta
(Gradoville et al., 2000; Lukac et al., 1998, 1999; Sun et al.,
1998). Rta possesses an amino-terminal DNA-binding domain,
a dimerization domain, a serine threonine-rich tract, two nuclear
localization signals (NLS), and a carboxy-terminal activation
domain. This protein architecture is reminiscent of other
transcription factors. KSHV Rta is functionally homologous
to the BRLF1 gene product encoded by Epstein–Barr virus
(EBV) and the Orf50 proteins encoded by rhesus rhadinovirus
(RRV), murine gammaherpesvirus 68 (MHV68), and herpesvi-
rus saimiri (HVS) (DeWire et al., 2002; Liu et al., 2000; Sun et
al., 1998; Wu et al., 2000). A comparison of KSHV, RRV, and
MHV68 Rta proteins demonstrated that all three proteins are
capable of activating transcription from several KSHV
promoters, indicating that the Rta proteins are closely related
(Damania et al., 2004). Additionally, HVS Orf50 has also been
shown to reactivate the HVS lytic cycle and to function as a
transcriptional activator of delayed early promoters (Goodwin
et al., 2001; Walters et al., 2004; Whitehouse et al., 1997). For
KSHV, the Rta protein alone is both necessary and sufficient to
induce lytic reactivation (Gradoville et al., 2000; Sun et al.,
1998). KSHV Rta transcripts are detected within 1 h after TPA
treatment (Lukac et al., 1999). Expression of Rta leads to the
activation of downstream lytic genes and ultimately the
production of progeny virions (Gradoville et al., 2000; Lukac
et al., 1999; Renne et al., 1996). However, expression of adominant negative Rta mutant that lacks the carboxy terminal
activation domain prevents spontaneous reactivation and
induction by chemical inducers(Lukac et al., 1999). The various
functions of the KSHV Rta protein have been well reviewed by
West and Wood (2003).
Rta has been shown to transactivate the promoters of a
number of lytic genes including K8 (K-bZIP), Orf57 (Mta),
polyadenylated nuclear (PAN) RNA (nut-1), Kaposin (K12),
K1, viral interleukin-6 (vIL-6), K5, K9, Orf59, thymidine
kinase (TK), vGPCR, K14, Orf6, Orf9, and Orf50 (Bowser et
al., 2002; Chen et al., 2000; Deng et al., 2002a, 2002b;
Haque et al., 2000; Jeong et al., 2001; Liang et al., 2002;
Lukac et al., 1998, 1999; Sakakibara et al., 2001; Song et al.,
2001; Wang et al., 2001a; Zhang et al., 1998). This
transactivation occurs through direct binding to Rta response
elements (RRE) or through an association with other factors
such as Oct-1, Sp1, RBP-Jκ (CSL), MGC2663, cAMP
response element binding protein (CREB)-binding protein
(CBP), c-Jun, and CCAAT/enhancer-binding protein-alpha (C/
EBPα) (Gwack et al., 2001; Liang and Ganem, 2004; Liang
et al., 2002; Sakakibara et al., 2001; Wang et al., 2001a,
2001b, 2003a, 2003b; Zhang et al., 1998).
For many of these promoters, transactivation occurs
through direct binding to RREs in the promoter. Rta binds
directly to the promoters of PAN, Kaposin, K8, Orf57, and
vIL-6 (Chang et al., 2002; Deng et al., 2002b; Duan et al.,
2001; Lukac et al., 1998, 1999; Song et al., 2002a, 2002b).
Early analysis of Rta transactivation demonstrated that Rta
bound to very similar response elements within the K8 and
Orf57 promoters (Lukac et al., 2001). The Rta-binding sites
within the PAN and Kaposin promoters are also very similar
to each other (Chang et al., 2002), however, the K8, Orf57,
and vIL-6-binding sites lack significant similarity to the PAN
and Kaposin Rta-binding sites (Chang et al., 2002; Deng et
al., 2002b; Duan et al., 2001; Lukac et al., 1998, 1999; Song
et al., 2002a, 2002b). In an attempt to explain the apparent
diversity associated with Rta binding, Liao et al. recently
identified a pattern of A/T triplets that confer Rta respon-
siveness (Liao et al., 2003). A/T motifs separated by 7 or 17-
bp GC-rich spacers were found in the K8, Orf57, PAN, and
Kaposin promoters and may be responsible for mediating Rta
binding to these promoters. However, the core Rta-binding
site in the vIL-6 promoter does not appear to share this
pattern (Deng et al., 2002b).
We have previously demonstrated that the K1 promoter is
activated by expression of Rta in B cells, endothelial and
epithelial cells (Bowser et al., 2002). The mechanism for this
activation, however, was unknown. Here, we found that the
activation of the K1 promoter by Rta occurs through direct
DNA binding to three binding sites within the K1 promoter,
independent of other DNA-binding proteins. Of these three
sites, only two appear to be functionally significant, and either
functional binding site is sufficient to provide Rta responsive-
ness to a heterologous promoter. Furthermore, two of the Rta-
binding sites in the K1 promoter conform to the A/T nucleotide
pattern described by Liao et al. (2003), but the third site
represents a new Rta-binding sequence. We also demonstrate an
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the K1 transcription start site. Coimmunoprecipitation analysis
revealed an association of Rta with TBP, suggesting that Rta
may function in part to recruit TBP to the TATA box. Overall,
our data suggest that Rta binds to the K1 promoter independent
of other factors and may recruit TBP to promote K1
transcription.
Results
Identification of RTA responsive elements (RREs) in the K1
promoter
Our previous data demonstrated that the first 125 bp
upstream of the K1 transcription start site are capable of
functioning as a fully active promoter element (Bowser et al.,
2002). To identify the sequences within this construct that
contribute directly to K1 promoter activity, we constructed a
panel of linker scanning mutants that contains sequential, 10-bp
substitutions of the 125-bp K1 promoter element and 5′
untranslated region in the context of the pGL2-Basic luciferase
vector (Promega). Overlapping BamHI and NcoI restriction
enzyme sites were substituted for the wild-type promoter
sequence as shown in Fig. 1A. The integrity of the promoter
mutants was confirmed by restriction digest (Fig. 1B) and
sequencing. Each of the linker scanning mutant plasmids was
cotransfected into KSHV-positive BCBL-1 B cells, KSHV-
negative DG75 B cells, or HEK 293 cells with either a
pcDNA3-Rta expression vector or empty pcDNA3 plasmid, and
a β-galactosidase expression plasmid to control for transfection
efficiency.
Although Rta could transactivate the wild-type −125K1p
promoter 13.5-fold in BCBL-1 cells, several of the K1
promoter linker scanning mutants demonstrated a reduced
responsiveness to Rta when compared to −125K1p. Linkers P8
(1.7-fold), P9 (3.0-fold), and P18 (2.4-fold) each displayed at
least a 75% reduction in Rta responsiveness (shown by the
dashed line) while linker P11 (5.1-fold) displayed more than a
50% reduction in Rta responsiveness (Fig. 2A). Luciferase
reporter assays were also performed in DG75 B cells to
corroborate the BCBL-1 data in an uninfected B cell line. In
the context of DG75 B cells, the wild-type −125K1p was
activated 17-fold. However, linker P11 (4.9-fold), linker P18
(7.3-fold), and linker P20 (7.0-fold) each demonstrated at least
a 50% reduction in responsiveness to Rta compared with the
wild-type K1 promoter (Fig. 2B). Rta responsiveness in
uninfected HEK 293 cells closely resembled Rta responsive-
ness in DG75 cells (Supplementary Fig. 1). We hypothesized
that since linkers P11 and P18 are less responsive to Rta in
each cell line, they represent the most likely locations for Rta
response elements.
The mutation introduced into K1 promoter linker scanning
mutant P11 resulted in a decreased responsiveness to Rta,
however, this mutation may have also affected the putative K1
TATA box which is located in the same region. An additional
K1 promoter mutant was therefore generated in which
mutations were introduced into sites predicted to disrupt theTATA box, while having a minimal effect on the responsive-
ness to Rta (TACTAATTTT to TGCGCATTTT). This mutant
was transfected into BCBL-1 cells along with either a Rta
expression vector or empty pcDNA3 vector, and promoter
activity was assessed by luciferase assays. The activity of the
K1 TATA mutant in the presence or absence of Rta was
compared with the wild-type K1 promoter sequence. The K1
TATA mutation completely abolished basal promoter activity
but retained 8.4-fold responsiveness to Rta (Fig. 2C). This is in
contrast to the wild-type promoter element which possesses
minimal basal activity in addition to being responsive to Rta.
Collectively, these reporter assays demonstrate a partial
uncoupling of the Rta response element and TATA box in
the K1 promoter.
Rta binds the K1 promoter in an electrophoretic mobility shift
assay (EMSA)
Our analysis indicates that Rta can activate the −125K1p
promoter fragment. This activation may be mediated by a direct
or indirect mechanism. Direct transactivation of the K1
promoter may occur through direct binding of Rta protein to
response elements within the K1 promoter. Indirect mechanisms
of K1 promoter activation include Rta binding to the K1
promoter by tethering to other bound transcription factors.
Alternatively, it is possible that Rta expression activates other
cellular or viral transcription factors, which in turn activate the
K1 promoter. To determine whether Rta activates the K1
promoter through direct contact with Rta response elements, an
electrophoretic mobility shift assay (EMSA) was performed
with the entire 125-bp K1 promoter element. The Rta DNA-
binding domain (amino acids 1–320) was expressed in BL21
(DE3)pLysS Escherichia coli (Stratagene) and purified by Ni-
NTA agarose purification as described previously (Song et al.,
2002b). This Rdbd protein was also tagged with a Flag epitope
(Song et al., 2002b). Bacterially expressed Rta has previously
been shown to bind Rta response elements in viral promoters by
several laboratories (Liao et al., 2003; Lukac et al., 2001; Song
et al., 2001, 2002b).
Rta has previously been shown to bind to a response element
within the PAN promoter (Song et al., 2001). This response
element was labeled and used in EMSA analysis to control for
Rta binding. In Fig. 3A, the addition of purified Rdbd in lane 3
results in the formation of a shifted complex confirming the
association of Rta with the PAN probe under these conditions.
The mobility of this complex is further retarded by the addition
of a monoclonal anti-FLAG antibody (lane 4), confirming that
Rta is present in the shifted complex in lane 3. Together, these
data indicate that the proper conditions were used to observe Rta
binding. Fig. 3B shows the results of EMSA analysis of the 125-
bp K1 promoter element with purified Rdbd. Lanes 1 and 2
represent probe alone and extract from untransformed BL21
cells, respectively. The addition of purified Rdbd in lane 3
results in the appearance of a complex with retarded mobility,
suggesting that Rta can directly bind to the 125-bp K1 promoter
fragment. To confirm that Rdbd is responsible for this shifted
complex, monoclonal anti-FLAG antibody (Sigma) was
Fig. 1. Panel of K1 promoter linker scanning mutants. (A) Diagram of linker scanning mutant panel. Sequential, 10-bp substitutions were made to the K1 promoter
element. Overlapping NcoI and BamHI restriction enzyme sites were substituted for the wild-type promoter sequence. The gray boxes indicate the location of each
mutation. Black arrows indicate the location of the transcription start site, while the white arrows indicate the translation start site. Base pair positions are given relative
to the K1 transcription start site. The panel of K1 mutants was made in the context of the pGL2-Basic luciferase vector (Promega). (B) Confirmation of mutagenesis.
Linker scanning mutants P1 through P10 were digested with NcoI and XhoI, while mutants P11 through P20 were digested with SacI and NcoI to confirm mutagenesis.
Digests were separated on a 1% agarose gel. Mutagenesis was also confirmed by plasmid sequencing (data not shown).
312 B.S. Bowser et al. / Virology 348 (2006) 309–327included in the binding reaction in lane 4. Anti-FLAG antibody
further retarded the mobility of the shifted species present in
lane 3, demonstrating that Rdbd is present in the shifted
complex. These results indicate that purified Rdbd binds
directly to the K1 promoter, independent of other DNA-binding
proteins.
Identification of Rta-binding sites within the K1 promoter
element
To identify the Rta-binding site(s) within the K1 promoter
element, a panel of 30-bp K1 promoter probes was generated for
use in additional EMSA experiments. Fig. 4 shows thealignment of these 30-mer probes with respect to the entire
K1 promoter element. Probes A to D sequentially span the
entire 125-bp K1 promoter element, while probes E to G
overlap probes A/B, B/C, and C/D, respectively. Linker
scanning mutant analysis indicated that the 5′ untranslated
region sequence mutated in linker P18 is also important for Rta
responsiveness (Figs. 2A and B). Therefore, probe H was
designed to test a 30-bp fragment of the 5′ untranslated region
immediately upstream of the translation start site.
EMSA analysis of the 30-bp probes was performed as
before, but additional controls were added to further confirm the
specificity of shifted and supershifted complexes. As a negative
control, extracts were prepared from BL21 cells that were left
Fig. 2. Identification of Rta response element(s). Rta activation of K1 promoter linker scanning mutants in KSHV-positive BCBL-1 B cells (A) and KSHV-negative
DG75 B cells (B). Each K1 promoter linker scanning mutant was cotransfected with a β-galactosidase expression vector to normalize for transfection efficiency, and
either a pcDNA3-Rta expression vector or empty pcDNA3 plasmid. The activation of the promoter by Rta is represented as fold activation over pcDNA3-transfected
controls. The dashed lines in panels A and B indicate a 75% reduction in responsiveness to Rta compared with the wild-type −125K1p plasmid. (C) Uncoupling of Rta
transactivation and TATA box activity. A K1 promoter luciferase plasmid with a mutated TATA box (…TACTAATTTT… to …TGCGCATTTT…) was cotransfected
with a β-galactosidase expression vector to normalize for transfection efficiency, and either a pcDNA3-Rta expression vector or empty pcDNA3 plasmid. The activity
of the mutant K1 promoter was compared with the activity of wild-type pGL2-Basic/-125K1p or empty pGL2-Basic. Promoter activity is represented as fold activation
over empty pGL2-Basic luciferase vector.
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and Ni-NTA purification as Rdbd-transformed cells. These
negative control samples were used to demonstrate any
background, nonspecific (NS) bands that may be carried
through the Ni-NTA purification. In addition, competition
experiments were performed in which an excess of unlabeledPAN Rta response element was added to the purified Rdbd
protein prior to the addition of probe. The PAN Rta response
element has previously been shown to bind very strongly to
purified Rdbd (Song et al., 2002b).
EMSA analysis of each 30-mer K1 promoter probe
demonstrated the presence of one or more nonspecific (NS)
Fig. 3. Rta electrophoretic mobility shift assay of the K1 promoter. The Rta DNA-binding domain was expressed in BL21 E. coli and purified by Ni-NTA purification.
The PAN Rta response element (A) or the K1 promoter (minus the 5′UTR) (B) was 32P-labeled and used in a mobility shift assay with purified Rta DNA-binding
domain. Lane 1: Probe alone, lane 2: untransformed BL21 negative control, lane 3: Rdbd shift, lane 4: Rdbd, anti-FLAG supershift.
314 B.S. Bowser et al. / Virology 348 (2006) 309–327background bands, contributed by the BL21 cells (Fig. 5).
These background bands were present in extracts from both
BL21 negative control extracts and purified Rdbd extracts.
Monoclonal anti-FLAG antibody was unable to supershift these
background bands regardless of which probe was being tested,
indicating that these background bands are not the result of Rta
binding and that the anti-FLAG antibody does not recognize
and supershift these background bands.
Rdbd failed to bind to probes A, B, C, D, and F as shown in
lane 4 of Figs. 5A, B, C, D, and F, respectively. However,
probes E, G, and H each demonstrated specific shifts in the
presence of Rdbd (Lane 4, Figs. 5E, G, H). These shifts were
supershifted with the addition of anti-FLAG antibody, indicat-Fig. 4. Panel of K1 promoter EMSA probes. A panel of 30-mer K1 promoter probes w
indicated. The location of each probe is shown in comparison with the intact K1 proing that Rta is responsible for this shifted complex (Lane 5,
Figs. 5E, G, H). Furthermore, incubation with an excess of
unlabeled PAN RRE efficiently competes for Rdbd, thereby
significantly reducing Rdbd-specific shifts and supershifts (lane
6, Figs. 5E, G, H), demonstrating that purified Rdbd specifically
binds to probes E, G, and H in the K1 promoter.
Functional contribution of the three Rta-binding sites in the K1
promoter
EMSA analysis demonstrated the existence of three Rta-
binding sites, two within the K1 promoter (E, G) and one within
the 5′ untranslated region (H). Interestingly, two of theseas generated for use in Rta EMSA analysis. The full-length −125K1p promoter is
moter. Nucleotide positions are given relative to the K1 transcription start site.
Fig. 5. Identification of Rta-binding sites within the K1 promoter by EMSA analysis. The Rta DNA-binding domain (amino acids 1–320) was expressed in BL21 E. c and purified by Ni-NTA purification. This purified
protein was used in EMSA analysis with the panel of K1 promoter probes diagrammed in Fig. 4. Panels A through H represent EMSA analysis with probes A throu H shown in Fig. 4, respectively. Rta-specific shifts
and supershifts in panels E, G, and H are indicated. Nonspecific (NS) bands are similarly indicated for each EMSA. Lane 1: probe alone, lane 2: untransformed BL egative control, lane 3: untransformed BL21 with
anti-FLAG antibody, lane 4: Rdbd extract, lane 5: Rdbd extract with anti-FLAG antibody, lane 6: Rdbd extract with anti-FLAG antibody and unlabeled PAN co etitor.
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316 B.S. Bowser et al. / Virology 348 (2006) 309–327binding sites, G and H, correlate with the reduced Rta
responsiveness associated with linkers P11 and P18 (Fig. 2A).
Mutation of either of these elements reduced but did not
completely eliminate Rta responsiveness (Fig. 2A). EMSA
probe E corresponds to the region mutated in linker P4, which
did not have a significant effect on Rta responsiveness in
reporter assays. To completely eliminate the responsiveness to
Rta, it may be necessary to mutate two, or perhaps all three Rta-
binding sites within the K1 promoter. Double and triple
mutations were therefore made to the three K1 Rta-binding
sites to analyze their combined contribution to promoter
activation. Fig. 6A diagrams these mutant plasmids. As before,
these mutations were made in the context of the pGL2-BasicFig. 6. Analysis of K1 promoter double/triple mutants. (A) Diagram of K1 promote
panel of double and triple mutants was generated in the context of the pGL2-Basic luc
D) Double/triple K1 promoter mutant activity in BCBL-1 B cells (B), uninfected DG
pGL2-Basic was transfected in parallel with the single, double, and triple mutants as s
transfection efficiency and either an Rta expression vector or empty pcDNA3 plasmid
transfected controls. (E) Diagram of K1 promoter deletion mutants. A panel of 30-bp
site identified by EMSA analysis. Numbered boxes indicate the location of the 10-bp l
30-bp regions identified as Rta-binding sites. (F) Each deletion mutant was transfecte
for transfection efficiency and either an Rta expression vector or empty pcDNA3 p
pcDNA3-transfected controls.luciferase vector. The single, double or triple K1 promoter
mutants were transfected into three different cell lines: KSHV-
positive BCBL-1 B cells, KSHV-negative DG75 B cells, and
KSHV-negative CV-1 fibroblasts. The promoter mutants were
transfected with either a pcDNA3-Rta expression vector or a
pcDNA3 plasmid, as well as a β-galactosidase expression
plasmid to control for transfection efficiency. As before,
mutation of linker P4 had little to no effect on the
responsiveness of the K1 promoter to Rta in each cell line
tested (Figs. 6B, C, and D). Single mutations of linker P11 and
P18 resulted in decreased activation by Rta. In the context of
BCBL-1 cells, linker P11 displayed a 5.4-fold activation, while
linker P18 was slightly lower with 1.7-fold activation (Fig. 6B).r mutants. In addition to the single linker scanning mutants P4, P11, and P18, a
iferase vector. Mutated sequences are indicated by open, labeled boxes. (B, C and
75 B cells (C), and CV-1 fibroblast cells (D), respectively. Wild-type -125K1p/
hown in panel A along with a β-galactosidase expression vector to normalize for
as a negative control. The data are represented as fold activation over pcDNA3-
deletion mutants was generated that possess 30-bp deletions at each Rta-binding
inker scanning substitutions described previously. Black boxes indicate the three,
d into BCBL-1 cells along with a β-galactosidase expression vector to normalize
lasmid as a negative control. The data are represented as fold activation over
317B.S. Bowser et al. / Virology 348 (2006) 309–327In DG75 B cells, activation of linkers P11 (4.8-fold) and P18
(3.3-fold) was also reduced, but not totally eliminated (Fig. 6C).
Finally, in CV-1 cells, linker P11 displayed a 2.6-fold activation
by Rta, while linker P18 displayed a 5.2-fold activation by Rta
(Fig. 6D).
In each cell line, the P4,P11 and P4,P18 double mutants both
had an intermediate response to Rta (Figs. 6B, C, and D). The
P11,P18 double mutant and P4,P11,P18 triple mutant, however,
both displayed little to no responsiveness to Rta in each cell line
(Figs. 6B, C, and D). In summary, these data suggest that linker
P4 does not significantly contribute to Rta responsiveness.
However, when both P11 and P18 are mutated, the K1 promoter
is no longer responsive to Rta, indicating that there are two
functionally significant Rta response elements in the K1
promoter.
The EMSA analysis presented in Fig. 5 made use of 30-bp
probes, while each K1 promoter luciferase plasmid was
designed with one or more 10-bp substitutions (Figs. 2A,
6A). In order to directly compare reporter assay data with
EMSA data, a panel of 30-bp K1 promoter deletion mutants was
generated for use in luciferase assays. These deletion mutants
are diagrammed in Fig. 6E and are designed to separately
remove each Rta-binding site identified by EMSA analysis in
Fig. 5. In addition, both the G and H Rta-binding sites were
removed in the K1p G, H deletion mutant similar to the double
substitution mutant P11, P18. These deletion mutants were
transfected into BCBL-1 cells with either a pcDNA3-Rta
expression vector or pcDNA3 vector, as well as a β-
galactosidase expression plasmid to control for transfection
efficiency and Rta responsiveness was assessed by luciferase
assays. The wild-type −125K1p plasmid was included for
comparison.
Deletion of the K1p E Rta-binding site did not affect Rta
responsiveness (Fig. 6F), similar to the P4 10-bp substitution
mutant used in Figs. 6B, C, and D. Deletion of either the K1p G
Rta-binding site or the K1p H Rta-binding site alone reduced
the level of Rta responsiveness, while a double deletion mutant
that lacks both the K1p G and K1p H Rta-binding sites
possessed no Rta responsiveness (Fig. 6F). These data agree
with the 10-bp substitution mutant luciferase data and indicate
that the G and H Rta-binding sites each contribute to Rta
responsiveness. A complete loss of Rta responsiveness occurred
only when both the G and H Rta-binding sites were removed.
Furthermore, the fold activation for each of the K1 promoter
deletion mutants is nearly identical to the fold activation for
each 10-bp substitution (Figs. 6B, F). Therefore, these data
confirm that the reduced Rta responsiveness observed with the
10-bp substitution mutants P11 and P18 correlates with deletion
of the corresponding Rta-binding sites identified by EMSA
analysis.
Rta-binding sites G and H impart Rta responsiveness to a
heterologous promoter
Each Rta-binding site in the K1 promoter, as identified by
EMSA, was cloned upstream of an E4 TATA box in the pE4T/
Luc plasmid (Song et al., 2003) to further assess the functionalrole of these Rta-binding sites. These constructs were named
pE4T-K1E, pE4T-K1G, and pE4T-K1H. The full-length, wild-
type K1 promoter (−125K1p) was also cloned into the pE4T-
Luc vector to demonstrate Rta responsiveness of the full-
length K1 promoter in this vector backbone. The pE4T-Luc
vector possesses an E4 TATA box cloned upstream of the
luciferase gene and has been used previously to study the
responsiveness of other Rta response elements to Rta in the
context of a heterologous promoter (Song et al., 2003). Each
luciferase plasmid was transfected into HEK 293 cells with
either a pcDNA3-Rta expression vector or empty pcDNA3
plasmid along with a β-galactosidase expression vector to
control for transfection efficiency. The results of this analysis
are represented as a fold activation over empty pcDNA3
control vector. In the context of the pE4T-Luc vector, the full-
length K1 promoter element was activated approximately 6-
fold by the expression of Rta (Fig. 7B). The E-binding site
plasmid (pE4T-K1E) was unresponsive to Rta expression.
However, the G- and H-binding sites were activated
approximately 3-fold by Rta (Fig. 7B). These data indicated
that the G and H Rta-binding sites were capable of imparting
Rta responsiveness to the heterologous E4 TATA box
promoter, and the sum of their activation was equivalent to
that of the full-length −125K1p.
Identification of a functional TATA box within the K1 promoter
To confirm that a sequence identified as a putative TATA
box in the K1 promoter can function as a TATA box, the
putative K1 TATA box was substituted for the SV40 TATA
box within the context of the pGL2-Promoter vector as shown
in Fig. 7C. The pGL2-Promoter/K1 TATA box plasmid was
transfected into DG75 cells, and its activity was determined by
luciferase assays as before (Fig. 7D). The activity of the K1
TATA box vector was compared with the promoter-less pGL2-
Basic vector and pGL2-Promoter/SV40 TATA. The activity of
these plasmids is represented as fold activation over empty
pGL2-Basic vector. The pGL2-Promoter/SV40 TATA vector
possessed 45.9-fold activity over pGL2-Basic, while pGL2-
Promoter/K1 TATA possessed 15.9-fold activity over pGL2-
Basic. Although the basal activity of pGL2-Promoter/K1
TATA is less than pGL2-Promoter/SV40 TATA, these data
indicate that the sequence identified as a K1 TATA box can be
placed in a heterologous promoter context and can effectively
function as a TATA box.
TATA box-binding protein (TBP) binds to the K1 TATA box
Electrophoretic mobility shift assays were performed to
determine whether the TATA box-binding protein (TBP)
could bind to the K1 TATA, TAATTTT. As a positive control
for TBP binding, oligonucleotides containing a consensus
TATA box (TATAAAA) were included in the EMSA analysis.
Incubation of the consensus TATA box probe with purified
TBP (Santa Cruz Biotech) resulted in the formation of a
complex with reduced mobility (Fig. 8A, lane 2). Incubation
with a monoclonal antibody to TBP (Covance, clone ITBP18)
Fig. 7. Rta-binding sites and the K1 TATA box in the context of heterologous promoter elements. (A) Diagram of the E4 TATA box plasmids used to compare K1 Rta
responsiveness in the context of a heterologous promoter. The full-length K1 promoter was cloned upstream of the E4 TATA box to indicate K1 promoter activity in the
context of the pE4T-Luc vector. K1E, K1G, K1H were cloned individually upstream of the E4 TATA box. (B) Each E4T luciferase plasmid was transfected into HEK
293 cells along with a β-galactosidase expression vector to normalize for transfection efficiency and either an Rta expression vector or empty pcDNA3 plasmid as a
negative control. The data are represented as Rta-fold activation over empty pcDNA3 vector. (C) The K1 TATA box was substituted for the SV40 TATA box in the
context of the pGL2-Promoter vector. Bold nucleotides represent the SV40 or K1 TATA box. (D) The pGL2-Promoter/K1 TATA and pGL2-Promoter/SV40 TATA
vectors were transfected into DG-75 B cells along with a β-galactosidase expression vector to normalize for transfection efficiency. The data are represented as fold
activation over empty pGL2-Basic vector.
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supershifted band (Fig. 8A, lane 3). This may indicate that the
binding of the anti-TBP antibody to TBP prevents its
association with the probe. Alternatively, this may reflect
the formation of a TBP–DNA–antibody complex that is too
large to enter the gel. Regardless, these data confirm the
presence of TBP in the shifted complex. For further
confirmation, an excess of unlabeled consensus TATA box
oligonucleotides were incubated with the consensus TATA
box probe and TBP and efficiently competed for binding to
TBP (Fig. 8A, lane 4).
Similar to the positive control, incubation of the K1 TATA
box probe with purified TBP resulted in the appearance of aband with reduced mobility (Fig. 8B, lane 2). Incubation with a
monoclonal antibody to TBP (Covance, clone ITBP18) again
weakened the shifted band but did not form a supershifted
complex (Fig. 8B, lane 3). Finally, incubation of the K1 TATA
box probe with TBP and an excess of unlabeled consensus
TATA box oligonucleotides inhibited the formation of a shifted
band (Fig. 8B, lane 4). These data indicate that TBP binds to the
K1 TATA box.
Additional competition experiments were included to
confirm the specificity of TBP binding. In Fig. 8C, unlabeled
consensus TATA box oligonucleotides (lane 4) or unlabeled
K1 TATA box oligonucleotides (lane 5) effectively competed
with a consensus TATA box probe for binding to TBP, while
Fig. 8. TBP EMSA analysis of the K1 TATA box. Consensus TATA box oligonucleotides (A, lane 1) and K1 TATA box oligonucleotides (B, lane1) were annealed and
32P-labeled for EMSA analysis. Purified TBP was added to examine complex formation (A, B, lane 2). A monoclonal anti-TBP antibody (Covance) was added (A, B,
lane 3) to confirm the presence of TBP in the shifted complex. An excess of unlabeled, annealed consensus TATA box oligonucleotides was added to compete for
binding to TBP (A, B, lane 4). Consensus TATA box oligonucleotides (C) or K1 TATA box oligonucleotides (D) were labeled, and the specificity of TBP binding was
determined through competition with unlabeled consensus TATA box oligonucleotides (C, lane 4; D, lane 3), K1 TATA box oligonucleotides (C, lane 5; D, lane 4), and
mutated K1 TATA box oligonucleotides (C, lane 6; D, lane 5). (E) Mutated K1 TATA box oligonucleotides were labeled and incubated with TBP in the presence (lane
3) or absence (lane 2) of a monoclonal anti-TBP antibody (Covance). Lane 1 depicts probe alone.
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did not compete for binding to TBP. In Fig. 8D, the
reciprocal experiment was performed; unlabeled consensus
TATA box oligonucleotides (lane 3) or unlabeled K1 TATA
box oligonucleotides (lane 4) competed with a K1 TATA box
probe for binding to TBP, while the mutated K1 TATA box
oligonucleotides (lane 5) did not compete for binding.
Finally, a mutated K1 TATA box probe was unable to bind
to TBP (Fig. 8E). These data confirm the specificity of TBP
binding.Coimmunoprecipitation of KSHV Rta with TBP
To determine whether KSHV Rta also interacts with TBP,
coimmunoprecipitation experiments were performed. TREx
BCBL-Rta cells (Nakamura et al., 2003) were treated with 1 μg
of doxycycline/ml for 36 h at 37 °C to induce expression of Rta.
Fig. 9A, lanes 1 and 2 represent immunoprecipitations
performed with lysates prepared from uninduced TREx-Rta
BCBL-1 cells, while lanes 3 and 4 were performed with lysates
prepared from doxycycline-induced TREx-Rta BCBL-1 cells.
Fig. 10. Confirmation of Rdbd EMSA binding specificity. (A) PAN Rta
response element oligonucleotides were labeled and incubated with purified
Rdbd in the presence of unlabeled PAN Rta response element oligonucleotides
(lane 3) or unlabeled, nonspecific oligonucleotides (lane 4). The arrow indicates
an Rta-specific shifted complex. Lane 1: Probe alone, lane 2: Rdbd shift. (B)
PAN Rta response element oligonucleotides were labeled and incubated with
purified Rdbd in the presence of 400 pmol (lanes 4, 6, and 8) or 800 pmol
(lanes 5, 7, and 9) of unlabeled K1 oligonucleotides representing Rta-binding
sites E (lanes 4 and 5), G (lanes 6 and 7), and H (lanes 8 and 9). The arrow
indicates an Rta-specific shifted complex. Lane 1: Probe alone, lane 2: Rdbd
shift, lane 3: Rdbd extract with 400 pmol of unlabeled PAN RRE competitor.
Fig. 9. Coimmunoprecipitation of KSHV Rta with TBP. (A) TREx-Rta BCBL-1
cells were treated with 1 μg doxycycline/ml (lanes 3, 4, 5) or were left untreated
for 36 h (lanes 1 and 2). Cell lysates were incubated with a polyclonal anti-Rta
antibody to immunoprecipitate Rta (lanes 2 and 4) or no antibody as a negative
control (lanes 1 and 3) and were immunoblotted with monoclonal anti-TBP
antibody. Input lysate was included to indicate endogenous TBP (lane 5). (B)
TREx-RTA BCBL-1 cells (lanes 4, 5, 6) or TREx BCBL-1 cells (lanes 1, 2, 3)
were treated with 1 μg doxycycline/ml for 36 h. Cell lysates were incubated with
a monoclonal anti-TBP antibody (lanes 2, 5) to immunoprecipitate TBP or anti-
HHV8 mCP as an irrelevant antibody control (lanes 3, 6) or no antibody as
negative control (lanes 1, 4). Samples were immunoblotted with a polyclonal
anti-Rta antibody. (C) TREx-Rta BCBL-1 cells (lanes 4, 5, 6) or TREx BCBL-1
cells (lanes 1, 2, 3) were treated with 1 μg doxycycline/ml for 36 h. Cell lysates
were immunoblotted with a polyclonal anti-Rta antibody to demonstrate Rta
expression in input lysates.
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detected (lanes 1 and 3). However, immunoprecipitations
performed with a polyclonal anti-RTA antibody efficiently
coimmunoprecipitated TBP (lane 4) indicating an interaction of
endogenous Rta with TBP. A low level of spontaneous
reactivation in these cells also showed that Rta interacted with
TBP in uninduced cells (lane 2). Input lysate was included in
lane 5 to demonstrate input TBP.
A reciprocal coimmunoprecipitation was performed (Fig. 9,
panel B). TREx-RTA BCBL-1 cells or TREx BCBL-1 cells
were treated with 1 μg of doxycycline/ml for 36 h at 37 °C then
harvested for coimmunoprecipitation analysis. Lanes 1, 2, and 3
represent lysates from the negative control TREx BCBL-1 cell
line, while lanes 4, 5, and 6 represent lysates from the inducible
TREx-Rta BCBL-1 cell line. Immunoprecipitation with a
monoclonal anti-TBP antibody in lane 5 brought down Rta in
the inducible cell line, while no Rta was coimmunoprecipitated
in the negative control cell line (lane 2). As additional negative
controls, lysates were incubated in the absence of anti-TBP
(lanes 1 and 4) or in the presence of an irrelevant antibody to
HHV8 minor capsid protein (mCP) (lanes 3 and 6). These data
demonstrate that KSHV Rta associates with endogenous TBP.
To demonstrate that we had induced Rta expression in the
TREx-Rta BCBL-1 cells, Western blots were performed oninput cell lysates, and the results of this analysis are shown in
Fig. 9, panel C. In lanes 1, 2, and 3, no Rta is induced in the
negative control TREx BCBL-1 cell line, as expected. Lanes 4,
5, and 6, however, demonstrate inducible expression of Rta in
the TREx-Rta BCBL-1 cell line.
The PAN RRE competes for binding to a K1 RRE
To demonstrate the specificity of Rta for Rta response
elements in the K1 promoter, unlabeled, nonspecific oligonu-
cleotides were included in a binding reaction with Rdbd and the
PAN probe (Fig. 10A). This nonspecific sequence was unable to
compete for binding to Rdbd (lane 4), while unlabeled PAN Rta
response element oligonucleotides specifically competed for
Rdbd binding (lane 3). These data indicate that Rta binding in
these EMSA analyses is not due to nonspecific binding. In
addition, we compared the binding affinities of the K1 Rta-
binding sites with the PAN RRE (Fig. 10B). The PAN RRE was
labeled and used as a probe. Rdbd binding to the PAN RRE was
effectively competed with 400 pmol of unlabeled PAN Rta
response element oligonucleotides (lane 3). Unlabeled K1 Rta-
binding site oligonucleotides were titrated from 400 to 800
pmol to compete with the PAN RRE probe for Rdbd binding
(Fig. 10B). Each K1 Rta-binding site effectively competed for
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oligonucleotides.
Discussion
Several functions have been described for the K1 protein of
Kaposi's sarcoma-associated herpesvirus. K1 inhibits apoptosis
and initiates signaling pathways that ultimately activate cellular
transcription factors (Lagunoff et al., 1999, 2001; Lee et al.,
1998a, 1998b; Samaniego et al., 2001; Tomlinson and Damania,
2004). K1 also has been shown to possess transforming
properties and to promote the formation of spindle-cell
sarcomatoid tumors and malignant plasmablastic lymphomas
in K1 transgenic mice (Lee et al., 1998b; Prakash et al., 2002).
However, little is known about how K1 transcription is
regulated. In our initial characterization of the K1 promoter,
we demonstrated that a fully functional promoter element is
contained within the first 125 bp upstream of the K1
transcription start site, and that the KSHV immediate-early
transcription factor, Rta, activated the K1 promoter above basal
levels (Bowser et al., 2002). Here, we explored the mechanism
of Rta activation using a panel of linker scanning promoter
mutants, reporter assays, coimmunoprecipitations, and electro-
phoretic mobility shift assays (EMSA).
Linker scanning mutations of promoters have proven to be a
useful tool to analyze functional promoter sequences for viral
and cellular promoters (Ahn et al., 1992; Hebbar and Archer,
2003; Zeichner et al., 1991). Rta expression activated most of
the linker scanning mutants of the K1 promoter to near wild-
type levels. However, linkers P8, P9, and P18 demonstrated a
greater than 75% reduction in Rta responsiveness in the context
of BCBL-1 cells, while linker P11 approached a 75% reduction
in responsiveness. Linkers P11 and P18 demonstrated nearly a
75% reduction in Rta responsiveness in the context of DG75
cells. These data suggest that the sequences mutated in linkers
P11 and P18 may function as Rta response elements since they
showed weakened activity in both cell lines. Interestingly,
linkers P8 and P9 demonstrated reduced responsiveness to Rta
in the context of BCBL-1 cells but not in the context of DG75
cells. These data raise the possibility that viral-specific factors
present in BCBL-1 cells may also contribute to Rta
responsiveness.
Reporter analysis of linker P10 only in the context of DG75
B cells resulted in greater activity than the wild-type sequence
(Fig. 2B). This increased responsiveness to Rta may reflect the
loss of a repressor binding site. Alternatively, these data may
reflect the inadvertent introduction of a transcription factor
binding site into the K1 promoter element. Although the choice
of linker sequence was made to minimize the potential of
introducing transcription factor binding sites, when placed in
the context of the surrounding K1 promoter sequence, the linker
could introduce such sites.
EMSA analysis with a 125-bp fragment of the K1 promoter,
which spans much of the functional promoter element, but lacks
the 5′ untranslated region indicated that Rta binds directly to the
K1 promoter (Fig. 3). EMSA analysis with smaller 30-mer
probes that spanned the K1 promoter demonstrated that Rtabinds to three sites (E, G, and H) within the K1 promoter element
(Figs. 5E, G, andH). Two of these binding sites, E andG, contain
sequences similar to the pattern of A/T triplets that have been
proposed to function as Rta-binding sites (Liao et al., 2003).
Probe E contains the sequence TTTCGGGCCCTTT which
agrees with the A/T3N7A/T3 pattern suggested by Liao et al.,
while probe G contains the sequence TTTTCGGCCGG-
CCCCTACTAATTwhich agrees with the A/T3N17A/T3 pattern
(Liao et al., 2003). Interestingly, it has recently been reported
that HVS Orf50 contains a DNA-binding domain that has
homology to an AT hook DNA-binding motif (Walters et al.,
2004). This AT hook motif, present in mammalian high mobility
group (HMG)I proteins, has previously been shown to be
capable of binding to the minor groove of stretches of AT base
pairs (Reeves and Nissen, 1990).
In contrast to probes E and G, probe H does not conform to
the A/T triplet pattern and is a unique binding sequence. Rta
binding to the vIL-6 core promoter has similarly been shown to
occur independent of either A/T triplet pattern (Deng et al.,
2002b). Overall, our data demonstrate that two of the three Rta-
binding sites identified within the K1 promoter conform to the
A/T triplet model for Rta binding. Furthermore, the Rta-binding
site identified by probe H represents a unique Rta-binding site
that does not conform to the A/T triplet pattern, suggesting the
existence of other sequence recognition motifs for this potent
viral transactivator.
The identification of three Rta-binding sites suggested that
K1 transcriptional activation by Rta could occur via multiple
Rta response elements. According to this model, mutation of
one Rta response element would reduce, but not totally
eliminate Rta responsiveness. This would explain why none
of the K1 promoter linker scanning mutants exhibited a total
loss of Rta responsiveness. To completely abolish Rta
responsiveness, a panel of double and triple mutants was
constructed. Reporter assays using these mutants confirmed our
hypothesis and identified two functional Rta response elements
in the K1 promoter. Rta was unable to activate a double mutant
in which the linker P11 and P18 sequences were both mutated
(Figs. 6B, C, and D).
Multiple Rta response elements have been discovered within
the promoters of other KSHV genes. Rta binds directly to a
response element within the PAN promoter located between base
pairs −69 and −38, and via an association with RBP-Jk at an
RBP-Jk site between base pairs −706 and −1450 (Liang et al.,
2002; Song et al., 2001, 2002b). More recently, Wang et al.
demonstrated that there are three Rta response elements within
the K8 promoter, two of which are regulated differentially based
on cell type (Wang et al., 2004). Rta activation of the K8 promoter
occurs through both direct binding (Lukac et al., 2001) and
through an association with C/EBPα (Wang et al., 2003a). Wang
et al. also identified an RBP-Jκ site that may contribute to Rta
responsiveness (Wang et al., 2004). However, Rta activation of
the K1 promoter involves two functional Rta response elements
that both bind directly to Rta. Whether Rta also associates with
cellular proteins bound to the K1 promoter remains to be
determined. Another characteristic that is unique to the K1
promoter is the presence of an Rta response element within the 5′
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K1 5′ untranslated region that reduces Rta responsiveness. This is
a novel finding since Rta has not been shown to bind to the 5′
untranslated region of other viral genes. However, many cellular
transcription factors have been shown to bind to the 5′ UTR of
several genes and activate their transcription (Rahaus and Wolff,
1999; van der Stoep et al., 2002).
Each Rta-binding site in the K1 promoter was cloned into the
pE4T-Luc vector to determine whether they would be able to
impart Rta responsiveness to a heterologous promoter. Inter-
estingly, the K1E Rta-binding site was unable to impart Rta
responsiveness to the E4 TATAvector, while K1G and K1H were
both able to provide Rta responsiveness (Fig. 7). These data
correlate nicely with the information presented in Fig. 6 in that
mutation at the K1E Rta-binding site did not affect Rta
responsiveness, but mutation of K1G and/or K1H resulted in
reduced Rta responsiveness.
In our previous analysis of the K1 promoter, we identified a
putative TATA box 25 bp upstream of the K1 transcription start
site (Bowser et al., 2002). Here, we demonstrate direct binding
of the TATA box binding protein (TBP) to a K1 promoter probe
containing the putative TATA box. Interestingly, the K1 TATA
box is adjacent to the K1G Rta-binding site, suggesting the
possibility of an interaction between KSHV Rta and TBP on the
K1 promoter. We demonstrate here for the first time a direct
interaction between the KSHV Rta protein and TBP. Rta may
promote transcription of K1 by first binding to the K1G binding
site and then recruiting the polymerase to the K1 TATA box
through a direct interaction with TBP. The downstream K1H-
binding site may promote transcription through interactions
with other factors, such as the TRAP/Mediator coactivator
(Gwack et al., 2003).
Materials and methods
Cell culture
KSHV-negative DG75 B cells were grown and maintained in
RPMI medium 1640 (Gibco BRL) with L-glutamine and 10%
fetal bovine serum (FBS) and supplemented with antibiotics
(streptomycin (50 μg/ml) and penicillin (100 U/ml)). KSHV-
positive BCBL-1 cells were grown and maintained in RPMI
medium 1640 (Gibco BRL) with L-glutamine, 10% fetal bovine
serum (FBS), 0.05 mM 2-mercaptoethanol, and 1 mM sodium
bicarbonate supplemented with antibiotics (streptomycin
(50 μg/ml) and penicillin (100 U/ml)). CV-1 fibroblast cells
were grown and maintained in Minimum Essential Medium
(Gibco BRL) with Earle's Salts, L-glutamine, and 10% fetal
bovine serum (FBS) and supplemented with 0.1 mM nones-
sential amino acids (Gibco BRL) and antibiotics (streptomycin
(50 μg/ml) and penicillin (100 U/ml)). HEK 293 cells were
grown and maintained in Dulbecco's modified Eagle's medium
(DMEM) (Gibco BRL) with 10% FBS, Glutamax I, high
glucose, 110 mg of sodium pyruvate/ml, and pyridoxine–HCl,
supplemented with streptomycin (50 μg/ml) and penicillin
(100 U/ml). All cell lines were grown and maintained at 37 °C
with 5% carbon dioxide.Plasmids
The luciferase reporter construct −125K1p/pGL2-Basic
contains the first 125 bp upstream of the K1 transcription start
site and the 5′ untranslated region, cloned into the pGL2-Basic
luciferase reporter plasmid (Promega) as previously described
(Bowser et al., 2002).
The −125K1p/pGL2-Basic construct was used as a wild-type
template for the production of a panel of K1 promoter linker
scanning mutants using the Stratagene QuikChange Site-
Directed Mutagenesis kit. DNA oligonucleotides were designed
to introduce sequential 10-bp substitutions to the wild-type K1
promoter sequence as diagrammed in Fig. 1A. Each primer
contained overlapping BamHI and NcoI restriction enzyme sites
and 15 bp complementary to the wild-type sequence on either
side of the target sequence. The primer sequences used to
generate this panel of mutants are listed in Table 1. Mutagenesis
was performed according to the manufacturer's instructions,
with 30 ng of −125K1p/pGL2-Basic as template. Thermo-
cycling conditions were as follows: an initial incubation at 95
°C for 30 s followed by 18 cycles of 95 °C for 30 s, 55 °C for
2 min, and 68 °C for 6 min. Restriction enzyme digests (Fig.
1B) and plasmid DNA sequencing confirmed mutagenesis.
Double and triple mutants of the K1 promoter were
generated using the Stratagene QuikChange Site-Directed
Mutagenesis kit as before. Linker P4 was used as a template
with P11 primers or P18 primers to generate both a P4,P11 and
P4,P18 double mutant, respectively. Linker P11 was used as a
template in a mutagenesis reaction with P18 primers to generate
a P11,P18 double mutant. Finally, the double mutant P4,P11
was used as a template with P18 primers to generate the triple
mutant P4,P11,P18. The panel of double and triple promoter
mutants is diagrammed in Fig. 6A. Restriction enzyme digests
and plasmid sequencing confirmed mutagenesis.
A panel of 30-bp deletion mutants of the K1 promoter was
generated using the Stratagene Site-Directed Mutagenesis kit as
before. The -125K1p/pGL2-Basic construct was used as a wild-
type template for the production of these 30-bp deletion
constructs. DNA oligonucleotides were designed to delete each
Rta-binding site within the K1 promoter, as diagrammed in Fig.
6E. K1p E deletion 1 5′-AGGCCACGCCTACTTCGAG-
CGGGGGACGGG-3′; K1p E deletion 2 5′-CCCGTCCC-
CCGCTCGAAGTAGGCGTGGCCT-3′; K1p G deletion 1 5′-
GCTAGGCCACGCCTAAAAGGCGGGGTTCTGC-3′; K1p
G deletion 2 5′-GCAGAACCCCGCCTTTTAGGCGT-
GGCCTAGC-3′; K1p H deletion 1 5′-CCTTGTGTAAA-
CCTGTCTCTCGAGATCTAAGTA-3′; K1p H deletion 2 5′-
TACTTAGATCTCGAGAGACAGGTTTACACAAGG-3′.
The K1p G deletion mutant was used as a template in a
mutagenesis reaction with K1p H oligonucleotides to generate a
double deletion mutant that lacks the G and H Rta-binding sites.
Restriction enzyme digests and plasmid sequencing confirmed
the construction of each plasmid.
Three 30-bp K1 promoter fragments were cloned into the
pE4T/Luc vector to determine whether these sequences are
sufficient to impart Rta responsiveness. The pE4T/Luc vector
contains the E4 TATA box in the context of the pGL3-basic
Table 1
Primers used to make K1 promoter linker scanning mutants
Primer sequence
Linker P1 Primer A 5′-GGAGGTACCGAGCTCCCATGGATCCTACTTTTTTTTTCGG-3′
Primer B 3′-CCTCCATGGCTCGAGGGTACCTAGGATGAAAAAAAAAGCC-5′
Linker P2 Primer A 5′-AGCTCAGGCCACGCCCCATGGATCCTTCGGGCCCTTTTTG-3′
Primer B 3′-TCGAGTCCGGTGCGGGGTACCTAGGAAGCCCGGGAAAAAC-5′
Linker P3 Primer A 5′-ACGCCTACTTTTTTTCCATGGATCCTTTTGGGCGCGCGAG-3′
Primer B 3′-TGCGGATGAAAAAAAGGTACCTAGGAAAACCCGCGCGCTC-5′
Linker P4 Primer A 5′-TTTTTTTCGGGCCCTCCATGGATCCGCGAGGCGAGCGGGG-3′
Primer B 3′-AAAAAAAGCCCGGGAGGTACCTAGGCGCTCCGCTCGCCCC-5′
Linker P5 Primer A 5′-GCCCTTTTTGGGCGCCCATGGATCCCGGGGGACGGGGCTA-3′
Primer B 3′-CGGGAAAAACCCGCGGGTACCTAGGGCCCCCTGCCCCGAT-5′
Linker P6 Primer A 5′-GGCGCGCGAGGCGAGCCATGGATCCGGCTAGGCCACGCCT-3′
Primer B 3′-CCGCGCGCTCCGCTCGGTACCTAGGCCGATCCGGTGCGGA-5′
Linker P7 Primer A 5′-GCGAGCGGGGGACGGCCATGGATCCCGCCTACTTTTTTTT-3′
Primer B 3′-CGCTCGCCCCCTGCCGGTACCTAGGGCGGATGAAAAAAAA-3′
Linker P8 Primer A 5′-GACGGGGCTAGGCCACCATGGATCCTTTTTTCGGCCGGCC-3′
Primer B 3′-CTGCCCCGATCCGGTGGTACCTAGGAAAAAAGCCGGCCGG-5′
Linker P9 Primer A 5′-GGCCACGCCTACTTTCCATGGATCCCGGCCCCTACTAATT-3′
Primer B 3′-CCGGTGCGGATGAAAGGTACCTAGGGCCGGGGATGATTAA-5′
Linker P10 Primer A 5′-ACTTTTTTTTTCGGCCCATGGATCCTAATTTTCAAAGGCG-3′
Primer B 3′-TGAAAAAAAAAGCCGGGTACCTAGGATTAAAAGTTTCCGC-5′
Linker P11 Primer A 5′-TCGGCCGGCCCCTACCCATGGATCCAGGCGGGGTTCTGCC-3′
Primer B 3′-AGCCGGCCGGGGATGGGTACCTAGGTCCGCCCCAAGACGG-5′
Linker P12 Primer A 5′-CCTACTAATTTTCAACCATGGATCCCTGCCAGGCATAGTC-3′
Primer B 3′-GGATGATTAAAAGTTGGTACCTAGGGACGGTCCGTATCAG-5′
Linker P13 Primer A 5′-TTCAAAGGCGGGGTTCCATGGATCCTAGTCTTTTTTTCTG-3′
Primer B 3′-AAGTTTCCGCCCCAAGGTACCTAGGATCAGAAAAAAAGAC-5′
Linker P14 Primer A 5′-GGGTTCTGCCAGGCACCATGGATCCTTCTGGCGGCCCTTG-3′
Primer B 3′-CCCAAGACGGTCCGTGGTACCTAGGAAGACCGCCGGGAAC-5′
Linker P15 Primer A 5′-AGGCATAGTCTTTTTCCATGGATCCCCTTGTGTAAACCTG-3′
Primer B 3′-TCCGTATCAGAAAAAGGTACCTAGGGGAACACATTTGGAC-5′
Linker P16 Primer A 5′-TTTTTTTCTGGCGGCCCATGGATCCACCTGTCTTTCAGAC-3′
Primer B 3′-AAAAAAAGACCGCCGGGTACCTAGGTGGACAGAAAGTCTG-5′
Linker P17 Primer A 5′-GCGGCCCTTGTGTAACCATGGATCCCAGACCTTGTTGGAC-3′
Primer B 3′-CGCCGGGAACACATTGGTACCTAGGGTCTGGAACAACCTG-5′
Linker P18 Primer A 5′-TGTAAACCTGTCTTTCCATGGATCCTGGACATCCTGTACA-3′
Primer B 3′-ACATTTGGACAGAAAGGTACCTAGGACCTGTAGGACATGT-5′
Linker P19 Primer A 5′-TCTTTCAGACCTTGTCCATGGATCCGTACATCAAGCTCGA-3′
Primer B 3′-AGAAAGTCTGGAACAGGTACCTAGGCATGTAGTTCGAGCT-5′
Linker P20 Primer A 5′-CTTGTTGGACATCCTCCATGGATCCCTCGAGATCTAAGTA-3′
Primer B 3′-GAACAACCTGTAGGAGGTACCTAGGGAGCTCTAGATTCAT-5′
Notes. Linkers P1, P2, P19, and P20 contain sequence complementary to the pGL2-Basic vector.
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previously (Song et al., 2003). Oligonucleotides were designed
with SacI and XhoI restriction enzyme sites to facilitate cloning
into the pE4T/Luc multiple cloning site. The following oligo-
nucleotides were used to PCR amplify the K1 promoter Rta-
binding sites using −125K1p/pGL2-Basic as template: E4T/K1E
primer 1 5′-CGCCGCGAGCT CTTTTTTTCGGGCCCTT-
TTTGGGCGCGCGAGG-3′ E4T/K1E Primer 2 5′-CG-
CCGCCTCGAGCCTCGCGCGCCCAAAAAGGGCC-
CGAAAAAAA-3′ E4T/K1G Primer 1 5′-CGCCGCGAGC-
TCCTTTTTTTTTCGGCCGGCCCCTACTAATTTTTC-3′
E4T/K1G Primer 2 5′-CGCCGCCTCGAGGAAAAATTAG-
TAGGGGCCGGCCGAAAAAAAAAG-3′ E4T/K1H Primer 1
5′-CGCCGCGAGCTCTT CAGACCTTGTTGGACA TCCT-
GTACATCAAG-3′ E4T/K1H Primer 2 5′-CGCCGCCT-
CGAGCTTGATGTACA GGATGTCCAACAAGGTCTGAA-
3′. PCR was performed using Platinum Pfx DNA polymerase
(Invitrogen) according to the manufacturer's directions. Ampli-fied K1 response elements were cut with SacI and XhoI
restriction enzymes and were inserted into the SacI and XhoI
sites of the pE4T/Luc vector. The entire K1 promoter element
was excised from −125K1p/pGL2-Basic by SacI/XhoI double
digest and was inserted into the SacI and XhoI sites of the pE4T/
Luc vector to generate pE4T/K1−125. Restriction enzyme digests
and plasmid sequencing confirmed the construction of each
plasmid.
A K1 TATA box construct was generated in which the SV40
TATA box contained within the pGL2-Promoter vector was
replaced with the K1 TATA box sequence, as shown in Fig. 7C.
The pGL2-Promoter vector was used as a template in a
mutagenesis reaction using the Stratagene Site-Directed Muta-
genesis kit, as before. DNA primers were designed as follows:
K1 TATA 1-5′-GGCTGACTAATTTTTTTTACTAATT-
TTGAGGCCGAGGCCGCCTCG-3′, K1 TATA 2-5′-CGAG-
GCGGCCTCGGCCTCAAAATTAGTAAAAAAAATT-
AGTCAG CC-3′. Restriction enzyme digests and plasmid
324 B.S. Bowser et al. / Virology 348 (2006) 309–327sequencing confirmed the construction of the mutant K1 TATA
box plasmid.
A mutant K1 TATA box luciferase plasmid was generated
using the Stratagene Site-Directed Mutagenesis kit as before.
The −125K1p/pGL2-Basic construct was used as a wild-type
template for the production of the K1 TATA mutant plasmid
with the following DNA oligonucleotides: K1 TATA mutant 1
5′-TTTTTTTCGGCCGGCCCCTGCGCATTTT CAAA-
GGCGGGGTTCTGCC-3′; K1 TATA mutant 2 5′-GGCA-
GAACCCCGCCTT TGAAAATGCGCAGGGGCCGGCC-
GAAAAAAA-3′. Restriction enzyme digests and plasmid
sequencing confirmed the construction of the K1 TATA
mutant plasmid.
Transfections
Each luciferase transfection was performed in duplicate or
triplicate, and each experiment was repeated five times.
KSHV-negative DG75 B cells and KSHV-positive BCBL-1
B cells were electroporated for luciferase assays. For each
transfection, 400 μl of cells in RPMI (no serum, no antibiotics)
at a concentration of 5 × 106 to 1 × 107 cells/ml was added to
0.4 cm cuvettes. To measure the promoter activity in the
presence of Rta, 15 μg of the appropriate K1 promoter
luciferase construct, 15 μg of pcDNA3-Rta (or pcDNA3), and
2 μg of a beta-galactosidase expression plasmid were added to
either cell line. The cells were electroporated at 300 V, 950 μF
and were added to 4 ml RPMI with 10% FBS and antibiotics.
The cells were incubated for 48 h at 37 °C with 5% carbon
dioxide. After 48 h, the cells were lysed in 200 μl of Promega
reporter lysis buffer for use in luciferase and beta-galactosidase
assays.
Transfections of HEK 293 cells and CV-1 African green
monkey kidney fibroblast cells were performed using the
Superfect transfection reagent (Qiagen). A total of 1.5 × 105
cells were seeded in 6-well plates in Minimal Essential Medium
with serum and antibiotics. Cells were grown overnight at 37 °C
with 5% CO2. The cells were transfected with 3 μg of luciferase
plasmid, 2 μg of Rta expression vector or pcDNA3 vector, and
1 μg of a β-galactosidase expression vector using 10 μl of
Superfect reagent according to the manufacturer's instructions.
Following the transfection, the cells were incubated for 48 h at
37 °C with 5% carbon dioxide. The cells were lysed in 200 μl of
Promega reporter lysis buffer for use in luciferase and beta-
galactosidase assays.
Luciferase assays
Luciferase assays were performed to measure the promoter
activity of each luciferase plasmid. Cell lysates were subjected
to a single freeze/thaw and were spun at 13,000 rpm for 2 min.
The supernatants were collected for luciferase and beta-
galactosidase analysis. One hundred microliters of cell lysate
was injected with 50 ml of Promega luciferase substrate and
luminescence was measured on a LMax luminometer (Molec-
ular Devices). Ten microliters of cell lysate was assayed for
beta-galactosidase activity using the Tropix Galacto-StarSystem (Applied Biosystems) according to the manufacturer's
instructions.
In the context of BCBL-1 and DG75 B cells, cotransfection
of empty pGL2-Basic vector with an Rta expression vector
resulted in higher luciferase activity than pcDNA3-transfected
controls, suggesting that Rta activates the empty luciferase
vector alone. The activation of empty vector by Rta was
subtracted from each luciferase assay to distinguish Rta's
activation of the K1 promoter from this background activation,
and each sample was normalized to beta-galactosidase activity,
as before. Following this adjustment, the values obtained for
each Rta-transfected sample were divided by those for the
corresponding pcDNA3-transfected control to indicate Rta
activation. The duplicates/triplicates for each experiment were
averaged, and standard deviations were calculated for each data
point.
Rta electrophoretic mobility shift assay (EMSA)
The Rta DNA-binding domain (Rdbd) (amino acids 1-320)
has been cloned into the pET22b(+) plasmid for expression in
bacteria (Song et al., 2002b). Rta expressed from this vector is
FLAG-tagged at its amino terminus and has six histidine
residues at its carboxy terminus. The Rdbd plasmid was
transformed into BL21(DE3)pLysS E. coli (Stratagene), and
Rdbd expression was induced with 1 mM IPTG for 2 h at
room temperature. Expressed Rdbd was purified via its
carboxy terminal histidine residues by Ni-NTA agarose
purification as described previously(Song et al., 2002b).
Untransformed BL21 cells were also treated with 1 mM
IPTG and subjected to Ni-NTA agarose purification for use as
a negative control.
The entire 125-bp promoter element was excised from a
pGL2-Basic plasmid which contains the 125-bp K1 promoter
element but lacks the 5′ untranslated region. The promoter
element was excised by SacI/XhoI double digest, and the ends
were filled-in by Klenow with 32P-dCTP and 32P-dATP. To
identify the Rta-binding site(s) within the 125-bp K1 promoter
element, a panel of 30-bp K1 promoter oligonucleotides that
spans the K1 promoter element was synthesized and is
diagrammed in Fig. 4. Probe H corresponds to the first 30 bp
upstream of the translation start site. Each probe was designed
with 5′ overhangs of 2 guanines to facilitate labeling by Klenow
fill-in with 32P-dCTP. A previously identified Rta response
element contained within the PAN promoter (PAN2) was also
labeled and used to control for Rta binding. The sequence of this
oligonucleotide was 5′-GGAAATGGGTGGCT AACCTGTC-
CAAAATATG-3′.
EMSA reactions were performed similarly to those described
previously (Song et al., 2001). Briefly, labeled probes
(5 × 105 cpm) were incubated for 30 min on ice with purified,
FLAG-tagged Rdbd protein (or BL21 negative control extract)
in binding buffer (10 mM Tris–HCl (pH 7.5), 150 mM KCl,
7.5 mMMgCl2, 1 mM EDTA, 2 μg salmon sperm DNA, 5 μg of
BSA, 0.5 mM dithiothreitol, 50 mM β-mercaptoethanol, 5%
glycerol). Binding reactions were separated on a 5% acrylamide
TGE gel. The gel was dried and exposed to a phosphorimager
325B.S. Bowser et al. / Virology 348 (2006) 309–327screen for 18 h and was scanned on a Molecular Dynamics
STORM 840 phosphorimager.
For supershift analysis, purified Rdbd (or BL21 negative
control extract) was incubated with labeled K1 promoter probe
for 15 min on ice. Following this incubation, 4 μl of
monoclonal anti-FLAG antibody (Sigma) was added, and the
binding reactions were incubated for an additional 30 min on
ice. Competition analysis was also performed to further
confirm the specificity of the binding interactions. To compete
for Rdbd binding, 400 or 800 pmol of unlabeled PAN2 Rta
response element, K1p E Rta-binding sequence, K1p G Rta-
binding site, or K1p H Rta-binding site was added to Rdbd,
and the binding reactions were incubated on ice for 15 min
(Song et al., 2001). Labeled K1 promoter probe was then
added, and the mixtures were again incubated for 15 min on
ice. Finally, 4 μl of monoclonal anti-FLAG antibody (Sigma)
was added, and the binding reactions were incubated on ice for
30 min. The binding reactions were then analyzed as before.
To further demonstrate the specificity of Rta binding, 500 ng
of poly [dG − dC] · poly [dG − dC] (Sigma) was added to
Rdbd prior to the addition of labeled PAN2 Rta response
element probe.
TATA binding protein (TBP) EMSA
Consensus TATA box oligonucleotides were designed as
follows: TATA 1 5′-gcagagcatataaaatgaggtagga-3′, TATA 2 5′-
tcctacctcattttatatgctctgc-3′. K1 TATA box oligonucleotides were
designed as follows: K1 TATA 1 5′-ggcggccggcccctactaatttt-
caaaggcgggg-3′, K1 TATA 2 5′-ggccccgcctttgaaaattag-
taggggccggccg-3′. Mutant K1 TATA box oligonucleotides
were designed as follows: K1 TATAmutant 1 5′-ggcggccggccc-
ctgcggcggcgcaaaggcgggg-3′, K1 TATAmutant 2 5′-ggccccgcct-
ttgcgccgccgc aggggccggccg-3′. The consensus TATA box oligo-
nucleotides, K1 TATA box oligonucleotides, and K1 TATA
mutant oligonucleotides were annealed and labeled as before
with 32P-dCTP. EMSA-binding reactions were assembled on
ice with 10% glycerol, 20 mM Tris (pH 8.0), 10 mM
magnesium chloride, 2 mM dithiothreitol (DTT), 80 mM
potassium chloride, 1 μg poly (dG:dC)·(dG:dC), and 5 μg of
purified TBP (Santa Cruz Biotechnology, Inc). For antibody
supershifts, 5 μl of Covance monoclonal anti-TBP antibody
(clone ITBP18) was added prior to the addition of probe. For
competition experiments, 300 pmol of annealed, unlabeled
consensus TATA box oligonucleotides, unlabeled K1 TATA box
oligonucleotides, or K1 TATA mutant oligonucleotides was
added before the addition of probe. The binding reactions were
incubated on ice for 15 min. To each binding reaction,
5 × 105 cpm of labeled probe was added. Binding reactions
were incubated on ice for an additional 45 min. The binding
reactions were separated on nondenaturing acrylamide gels with
0.5× TBE, 6% acrylamide (19:1 acrylamide:bis), 4 mM
magnesium chloride, and 0.02% NP-40. The running buffer
contained 0.5× TBE, 4 mM magnesium chloride, and 0.02%
NP-40. The gel was dried and exposed to a phosphorimager
screen for 18 h and was scanned on a Molecular Dynamics
STORM 840 phosphorimager.Coimmunoprecipitation analysis
TREx-Rta BCBL-1 cells or TREx BCBL-1 cells were
grown to approximately 3 × 107 cells per flask and were
induced with 1 μg doxycycline/ml or were given an equivalent
volume of water as a negative control. The cells were
incubated at 37 °C, 5% CO2 for 36 h, then were harvested
in radioimmunoprecipitation lysis buffer for Western blots or
NP-40 lysis buffer (150 mM NaCl, 0.1% NP-40, 50 mM Tris–
Cl [pH 8.0]) for immunoprecipitations. Coimmunoprecipita-
tion lysates were precleared with protein A/G beads (Santa
Cruz Biotechnology; A0704) for 2 h at 4 °C, then incubated
with 5 μl of polyclonal anti-RTA antibody, 5 μl of monoclonal
anti-TBP (Covance, clone ITBP18) or 5 μl of sheep anti-
HHV8 minor capsid protein (mCP) (Exalpha Biologicals, Inc.)
for 18 h at 4 °C. Lysates incubated in the absence of antibody
were included to serve as negative controls. Protein A/G beads
were added and incubated at 4 °C for 4 h. Complexes were
washed four times in NP-40 lysis buffer, incubated at 70 °C
for 5 min in sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) loading buffer and separated on a
10% SDS polyacrylamide gel.
Acknowledgments
We thank Dr. Jae Jung for the TREx-BCBL-1 and TREx-Rta
BCBL-1 cell line. We thank Stuart Krall for the assistance with
the cell lines. We also thank members of the Damania laboratory
for informative discussions and D. Dittmer for manuscript
reading. This work was supported by grants from the American
Association for Cancer Research (AACR) and NIH grant
CA096500 to BD and NIH grant CA91791 to R. Sun. BD is a
Leukemia and Lymphoma Society Scholar.
Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.virol.2006.02.007.
References
Ahn, J.K., Pitluk, Z.W., Ward, D.C., 1992. The GC box and TATA transcription
control elements in the P38 promoter of the minute virus of mice are
necessary and sufficient for transactivation by the nonstructural protein NS1.
J. Virol. 66 (6), 3776–3783.
Albrecht, J.C., Nicholas, J., Biller, D., Cameron, K.R., Biesinger, B., Newman,
C., Wittmann, S., Craxton, M.A., Coleman, H., Fleckenstein, B., et al., 1992.
Primary structure of the herpesvirus saimiri genome. J. Virol. 66 (8),
5047–5058.
Alexander, L., Denenkamp, L., Knapp, A., Auerbach, M., Czajak, S., Damania,
B., Desrosiers, R.C., 2000. The Primary Sequence of Rhesus Rhadinovirus
Isolate 26-95: sequence similarities to Kaposi's sarcoma herpesvirus and
rhesus rhadinovirus isolate 17577. J. Virol. 74 (7), 3388–3398.
Bowser, B.S., DeWire, S.M., Damania, B., 2002. Transcriptional regulation of
the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J. Virol.
76 (24), 12574–12583.
Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., Knowles, D.M., 1995.
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-
related body-cavity-based lymphomas. N. Engl. J. Med. 332 (18),
1186–1191.
326 B.S. Bowser et al. / Virology 348 (2006) 309–327Chang, P.J., Shedd, D., Gradoville, L., Cho, M.S., Chen, L.W., Chang, J., Miller,
G., 2002. Open reading frame 50 protein of Kaposi's sarcoma-associated
herpesvirus directly activates the viral PAN and K12 genes by binding to
related response elements. J. Virol. 76 (7), 3168–3178.
Chen, J., Ueda, K., Sakakibara, S., Okuno, T., Yamanishi, K., 2000.
Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus
viral interferon regulatory factor gene. J. Virol. 74 (18), 8623–8634.
Damania, B., Li, M., Choi, J.K., Alexander, L., Jung, J.U., Desrosiers, R.C.,
1999. Identification of the R1 oncogene and its protein product from the
Rhadinovirus of Rhesus monkeys. J. Virol. 73 (6), 5123–5131.
Damania, B.J.J., Bowser, B.S., DeWire, S.M., Staudt, M., Dittmer, D.P., 2004.
Comparison of the Rta/Orf50 transactivator Proteins of Gamma-2
herpesviruses. J. Virol. 78 (10), 5491–5499.
Deng, H., Chu, J.T., Rettig, M.B., Martinez-Maza, O., Sun, R., 2002a. Rta of the
human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates
human interleukin-6 gene expression. Blood 100 (5), 1919–1921.
Deng, H., Song, M.J., Chu, J.T., Sun, R., 2002b. Transcriptional regulation of
the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated
herpesvirus). J. Virol. 76 (16), 8252–8264.
DeWire, S.M., McVoy, M.A., Damania, B., 2002. Kinetics of expression of
rhesus monkey rhadinovirus (RRV) and identification and characterization
of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and
R8.1 Genes. J. Virol. 76 (19), 9819–9831.
Duan, W., Wang, S., Liu, S., Wood, C., 2001. Characterization of Kaposi's
sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter.
Arch. Virol. 146 (2), 403–413.
Duboise, S.M., Guo, J., Czajak, S., Desrosiers, R.C., Jung, J.U., 1998. STP and
Tip are essential for herpesvirus saimiri oncogenicity. J. Virol. 72 (2),
1308–1313.
Ganem, D., 1998. Human herpesvirus 8 and its role in the genesis of Kaposi's
sarcoma. Curr. Clin. Top. Infect. Dis. 18, 237–251.
Goodwin, D.J., Walters, M.S., Smith, P.G., Thurau, M., Fickenscher, H.,
Whitehouse, A., 2001. Herpesvirus saimiri open reading frame 50 (Rta)
protein reactivates the lytic replication cycle in a persistently infected A549
cell line. J. Virol. 75 (8), 4008–4013.
Gradoville, L., Gerlach, J., Grogan, E., Shedd, D., Nikiforow, S., Metroka, C.,
Miller, G., 2000. Kaposi's sarcoma-associated herpesvirus open reading
frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2
primary effusion lymphoma cell line. J. Virol. 74 (13), 6207–6212.
Gwack, Y., Byun, H., Hwang, S., Lim, C., Choe, J., 2001. CREB-binding
protein and histone deacetylase regulate the transcriptional activity of
Kaposi's sarcoma-associated herpesvirus open reading frame 50. J. Virol. 75
(4), 1909–1917.
Gwack, Y., Baek, H.J., Nakamura, H., Lee, S.H., Meisterernst, M., Roeder,
R.G., Jung, J.U., 2003. Principal role of TRAP/Mediator and SWI/SNF
complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated
lytic reactivation. Mol. Cell. Biol. 23 (6), 2055–2067.
Haque, M., Chen, J., Ueda, K., Mori, Y., Nakano, K., Hirata, Y., Kanamori, S.,
Uchiyama, Y., Inagi, R., Okuno, T., Yamanishi, K., 2000. Identification and
analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J. Virol.
74 (6), 2867–2875.
Hebbar, P.B., Archer, T.K., 2003. Nuclear factor 1 is required for both
hormone-dependent chromatin remodeling and transcriptional activation
of the mouse mammary tumor virus promoter. Mol. Cell. Biol. 23 (3),
887–898.
Jeong, J., Papin, J., Dittmer, D., 2001. Differential regulation of the overlapping
Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73)
promoters. J. Virol. 75 (4), 1798–1807.
Lagunoff, M., Ganem, D., 1997. The structure and coding organization of the
genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236
(1), 147–154.
Lagunoff, M., Majeti, R., Weiss, A., Ganem, D., 1999. Deregulated signal
transduction by the K1 gene product of Kaposi's sarcoma-associated
herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 96 (10), 5704–5709.
Lagunoff, M., Lukac, D.M., Ganem, D., 2001. Immunoreceptor tyrosine-based
activation motif-dependent signaling by Kaposi's sarcoma-associated
herpesvirus K1 protein: effects on lytic viral replication. J. Virol. 75 (13),
5891–5898.Lee, H., Guo, J., Li, M., Choi, J.K., DeMaria, M., Rosenzweig, M., Jung, J.U.,
1998a. Identification of an immunoreceptor tyrosine-based activation motif
of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus.
Mol. Cell. Biol. 18 (9), 5219–5228.
Lee, H., Veazey, R., Williams, K., Li, M., Guo, J., Neipel, F., Fleckenstein, B.,
Lackner, A., Desrosiers, R.C., Jung, J.U., 1998b. Deregulation of cell
growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat.
Med. 4 (4), 435–440.
Lee, B.S., Paulose-Murphy, M., Chung, Y.H., Connlole, M., Zeichner, S., Jung,
J.U., 2002. Suppression of tetradecanoyl phorbol acetate-induced lytic
reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal
transduction. J. Virol. 76 (23), 12185–12199.
Lee, B.S., Connole, M., Tang, Z., Harris, N.L., Jung, J.U., 2003. Structural
analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J. Virol.
77 (14), 8072–8086.
Liang, Y., Ganem, D., 2004. RBP-J (CSL) is essential for activation of the K14/
vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic
switch protein RTA. J. Virol. 78 (13), 6818–6826.
Liang, Y., Chang, J., Lynch, S.J., Lukac, D.M., Ganem, D., 2002. The lytic
switch protein of KSHVactivates gene expression via functional interaction
with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes
Dev. 16 (15), 1977–1989.
Liao, W., Tang, Y., Kuo, Y.L., Liu, B.Y., Xu, C.J., Giam, C.Z., 2003. Kaposi's
sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activa-
tor Rta is an oligomeric DNA-binding protein that interacts with tandem
arrays of phased A/T-trinucleotide motifs. J. Virol. 77 (17), 9399–9411.
Liu, S., Pavlova, I.V., Virgin, H.W., Speck, S.H., 2000. Characterization of
gammaherpesvirus 68 gene 50 transcription. J. Virol. 74 (4), 2029–2037.
Lukac, D.M., Renne, R., Kirshner, J.R., Ganem, D., 1998. Reactivation of
Kaposi's sarcoma-associated herpesvirus infection from latency by
expression of the ORF 50 transactivator, a homolog of the EBV R protein.
Virology 252 (2), 304–312.
Lukac, D.M., Kirshner, J.R., Ganem, D., 1999. Transcriptional activation by the
product of open reading frame 50 of Kaposi's sarcoma-associated
herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73
(11), 9348–9361.
Lukac, D.M., Garibyan, L., Kirshner, J.R., Palmeri, D., Ganem, D., 2001. Dna
binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is
necessary for transcriptional activation of two viral delayed early promoters.
J. Virol. 75 (15), 6786–6799.
Martin, D.F., Kuppermann, B.D., Wolitz, R.A., Palestine, A.G., Li, H.,
Robinson, C.A., 1999. Oral ganciclovir for patients with cytomegalovirus
retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
N. Engl. J. Med. 340 (14), 1063–1070.
Moore, P.S., Chang, Y., 1995. Detection of herpesvirus-like DNA sequences in
Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J.
Med. 332 (18), 1181–1185.
Murthy, S.C., Trimble, J.J., Desrosiers, R.C., 1989. Deletion mutants of
herpesvirus saimiri define an open reading frame necessary for transforma-
tion. J. Virol. 63 (8), 3307–3314.
Nakamura, H., Lu, M., Gwack, Y., Souvlis, J., Zeichner, S.L., Jung, J.U., 2003.
Global changes in Kaposi's sarcoma-associated virus gene expression
patterns following expression of a tetracycline-inducible Rta transactivator.
J. Virol. 77 (7), 4205–4220.
Prakash, O., Tang, Z.Y., Peng, X., Coleman, R., Gill, J., Farr, G., Samaniego, F.,
2002. Tumorigenesis and aberrant signaling in transgenic mice expressing
the human herpesvirus-8 k1 gene. J. Natl. Cancer Inst. 94 (12), 926–935.
Rahaus, M., Wolff, M.H., 1999. Influence of different cellular transcription
factors on the regulation of varicella-zoster virus glycoproteins E (gE) and I
(gI) UTR's activity. Virus Res. 62 (1), 77–88.
Reeves, R., Nissen, M.S., 1990. The A.T-DNA-binding domain of mammalian
high mobility group I chromosomal proteins. A novel peptide motif for
recognizing DNA structure. J. Biol. Chem. 265 (15), 8573–8582.
Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D.,
Ganem, D., 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus
(human herpesvirus 8) in culture. Nat. Med. 2 (3), 342–346.
Sakakibara, S., Ueda, K., Chen, J., Okuno, T., Yamanishi, K., 2001. Octamer-
binding sequence is a key element for the autoregulation of Kaposi's
327B.S. Bowser et al. / Virology 348 (2006) 309–327sarcoma-associated herpesvirus ORF50/Lyta gene expression. J. Virol. 75
(15), 6894–6900.
Samaniego, F., Pati, S., Karp, J., Prakash, O., Bose, D., 2001. Human
herpesvirus 8 k1-associated nuclear factor-kappa b-dependent promoter
activity: role in Kaposi's sarcoma inflammation? J. Natl. Cancer Inst.
Monogr. 28, 15–23.
Song, M.J., Brown, H.J., Wu, T.T., Sun, R., 2001. Transcription activation of
polyadenylated nuclear RNA by rta in human herpesvirus 8/Kaposi's
sarcoma-associated herpesvirus. J. Virol. 75 (7), 3129–3140.
Song, J., Ohkura, T., Sugimoto, M., Mori, Y., Inagi, R., Yamanishi, K.,
Yoshizaki, K., Nishimoto, N., 2002a. Human interleukin-6 induces human
herpesvirus-8 replication in a body cavity-based lymphoma cell line. J. Med.
Virol. 68 (3), 404–411.
Song, M.J., Li, X., Brown, H.J., Sun, R., 2002b. Characterization of interactions
between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's
sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 76 (10),
5000–5013.
Song, M.J., Deng, H., Sun, R., 2003. Comparative study of regulation of RTA-
responsive genes in Kaposi's sarcoma-associated herpesvirus/human
herpesvirus 8. J. Virol. 77 (17), 9451–9462.
Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet,
P., d'Agay, M.F., Clauvel, J.P., Raphael, M., Degos, L., et al., 1995. Kaposi's
sarcoma-associated herpesvirus-like DNA sequences in multicentric Cas-
tleman's disease. Blood 86 (4), 1276–1280.
Staskus, K.A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R.,
Beneke, J., Pudney, J., Anderson, D.J., Ganem, D., Haase, A.T., 1997.
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial
(spindle) tumor cells. J. Virol. 71 (1), 715–719.
Staskus, K.A., Sun, R., Miller, G., Racz, P., Jaslowski, A., Metroka, C., Brett-
Smith, H., Haase, A.T., 1999. Cellular tropism and viral interleukin-6
expression distinguish human herpesvirus 8 involvement in Kaposi's
sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
J. Virol. 73 (5), 4181–4187.
Sun, R., Lin, S.F., Gradoville, L., Yuan, Y., Zhu, F., Miller, G., 1998. A viral
gene that activates lytic cycle expression of Kaposi's sarcoma-associated
herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 95 (18), 10866–10871.
Tomlinson, C.C., Damania, B., 2004. The K1 protein of Kaposi's sarcoma-
associated herpesvirus activates the Akt signaling pathway. J. Virol. 78 (4),
1918–1927.
van der Stoep, N., Quinten, E., van den Elsen, P.J., 2002. Transcriptional
regulation of the MHC class II trans-activator (CIITA) promoter III:
identification of a novel regulatory region in the 5′-untranslated region and
an important role for cAMP-responsive element binding protein 1 and
activating transcription factor-1 in CIITA-promoter III transcriptional
activation in B lymphocytes. J. Immunol. 169 (9), 5061–5071.
Virgin, H.W.t., Latreille, P., Wamsley, P., Hallsworth, K., Weck, K.E., Dal
Canto, A.J., Speck, S.H., 1997. Complete sequence and genomic analysis of
murine gammaherpesvirus 68. J. Virol. 71 (8), 5894–5904.Walters, M.S., Hall, K.T., Whitehouse, A., 2004. The herpesvirus saimiri open
reading frame (ORF) 50 (Rta) protein contains an at hook required for
binding to the ORF 50 response element in delayed-early promoters. J. Virol.
78 (9), 4936–4942.
Wang, S., Liu, S., Wu, M., Geng, Y., Wood, C., 2001a. Kaposi's sarcoma-
associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a
potent C-terminal activation domain which activates gene expression via a
specific target sequence. Arch. Virol. 146 (7), 1415–1426.
Wang, S., Liu, S., Wu, M.H., Geng, Y., Wood, C., 2001b. Identification of a
cellular protein that interacts and synergizes with the RTA (ORF50) protein
of Kaposi's sarcoma-associated herpesvirus in transcriptional activation.
J. Virol. 75 (24), 11961–11973.
Wang, S.E., Wu, F.Y., Fujimuro, M., Zong, J., Hayward, S.D., Hayward, G.S.,
2003a. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in
activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-
cycle replication-associated protein (RAP) promoter in cooperation with the
KSHV replication and transcription activator (RTA) and RAP. J. Virol. 77
(1), 600–623.
Wang, S.E., Wu, F.Y., Yu, Y., Hayward, G.S., 2003b. CCAAT/enhancer-binding
protein-alpha is induced during the early stages of Kaposi's sarcoma-
associated herpesvirus (KSHV) lytic cycle reactivation and together with the
KSHV replication and transcription activator (RTA) cooperatively stimu-
lates the viral RTA, MTA, and PAN promoters. J. Virol. 77 (17),
9590–9612.
Wang, Y., Chong, O.T., Yuan, Y., 2004. Differential regulation of K8 gene
expression in immediate-early and delayed-early stages of Kaposi's
sarcoma-associated herpesvirus. Virology 325 (1), 149–163.
West, J.T., Wood, C., 2003. The role of Kaposi's sarcoma-associated
herpesvirus/human herpesvirus-8 regulator of transcription activation
(RTA) in control of gene expression. Oncogene 22 (33), 5150–5163.
Whitehouse, A., Carr, I.M., Griffiths, J.C., Meredith, D.M., 1997. The
herpesvirus saimiri ORF50 gene, encoding a transcriptional activator
homologous to the Epstein–Barr virus R protein, is transcribed from two
distinct promoters of different temporal phases. J. Virol. 71 (3),
2550–2554.
Wu, T.T., Usherwood, E.J., Stewart, J.P., Nash, A.A., Sun, R., 2000. Rta of
murine gammaherpesvirus 68 reactivates the complete lytic cycle from
latency. J. Virol. 74 (8), 3659–3667.
Zeichner, S.L., Kim, J.Y., Alwine, J.C., 1991. Linker-scanning mutational
analysis of the transcriptional activity of the human immunodeficiency virus
type 1 long terminal repeat. J. Virol. 65 (5), 2436–2444.
Zhang, L., Chiu, J., Lin, J.C., 1998. Activation of human herpesvirus 8 (HHV-8)
thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene
product is SP1 dependent. DNA Cell Biol. 17 (9), 735–742.
Zhong, W., Wang, H., Herndier, B., Ganem, D., 1996. Restricted
expression of Kaposi sarcoma-associated herpesvirus (human herpesvi-
rus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. U.S.A. 93 (13),
6641–6646.
